Collaborative network to develop biomarkers. Collaborative network between clinicians, researchers, and the pharmaceutical industry. Samples and data are shared among medical centers, the CIDR, centralized sample and digital biobanks, and the pharmaceutical industry. Data are also shared with regulatory authorities. This cooperation would speed development of biomarkers that are critical to help physicians make decisions that help patients. ASCO, American Society of Clinical Oncology; ASTCT, American Society for Transplant and Cellular Therapy; EBMT, European Society for Blood and Marrow Transplantation; EHA, European Hematology Association; EMA, European Medicines Agency; HRSA, Health Resources and Services Administration; ISCT, International Society for Cell & Gene Therapy; JDCHCT, Japanese Data Center for Hematopoietic Cell Transplantation; JSHCT, Japan Society for Hematopoietic Stem Cell Transplantation; NIH, National Institutes of Health; SITC, Society for Immunotherapy of Cancer.